The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Supply Chain Strategies & Solutions Article
Medical device manufacturers have been working hard to comply with the new Unique Device Identification (UDI) regulations from the FDA that are aim
Supply Chain Strategies & Solutions Article
Healthcare reform is driving unprecedented changes in the management, funding and delivery of care as hospitals develop and implement strategies to
Supply Chain Strategies & Solutions Article
The evolution of our healthcare system from a volume-based to a value-based model is driving provider organizations to adopt patient-centric, outco
Supply Chain Strategies & Solutions Article
HealthTrust recently created the Physician Advisors Program, which is narrowing the chasm between those who purchase products and those who use the
Supply Chain Strategies & Solutions Article
When I started in supply chain, the position that was presented afforded me the opportunity to utilize my clinical and business skills with the goa
White Papers
This paper explores the application of the Baldrige Excellence Framework to the health care supply chain.